Gastric cancer (GC) is one of the most common tumors worldwide and the leading cause of
tumor-related mortality. Endoscopy and serological tumor marker testing are currently the …

The fourth common reason of death among patients is gastric cancer (GC) and it is a
dominant tumor type in Ease Asia. One of the problems in GC therapy is chemoresistance …

Aims Treatment resistance commonly emerges in small cell lung cancer (SCLC),
necessitating the development of novel and effective biomarkers to dynamically assess …

Current management of small cell lung cancer (SCLC) remains challenging. Effective
biomarkers are needed to subdivide patients presenting distinct treatment response and …

Background Gastric cancer with peritoneal metastasis (PM-GC), recognized as one of the
deadliest cancers. However, whether and how the tumor cell-extrinsic tumor …

Gastric cancer (GC) is a prominent contributor to global cancer‑related mortalities, and a
deeper understanding of its molecular characteristics and tumor heterogeneity is required …

As a cancer type potentially dominated by copy number variations, ovarian cancer shows
hyperploid karyotypes and large-scale chromosome alterations, which might be promising …

Simple Summary Circulating tumor cells (CTCs) and CD31+ circulating tumor endothelial
cells (CTECs) constitute a unique pair of cellular circulating tumor biomarkers and play a …

Prognosticating the efficacy of anti‐angiogenic therapy through longitudinal monitoring and
early detection of treatment resistance in cancer patients remain highly challenging. In this …

An optimum safety excision margin (EM) delineated by precise demarcation of field
cancerization along with reliable biomarkers that enable predicting and timely evaluating …